The results of GSEA demonstrated that the pathways enriched in the low‐FREM1 expression group are related to cell metabolism, protein synthesis and folding, and cancer‐related signaling, therefore, deletion of this gene might result in a broad alterations of tumor cell biological behaviors. The gene discussed is FREM1; the disease is cancer.